These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23608531)

  • 1. Osteoporosis treatment: focus on safety.
    Reid IR
    Eur J Intern Med; 2013 Dec; 24(8):691-7. PubMed ID: 23608531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of bisphosphonates.
    Orozco C; Maalouf NM
    Rheum Dis Clin North Am; 2012 Nov; 38(4):681-705. PubMed ID: 23137577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiresorptive Therapies for Osteoporosis.
    Weinerman S; Usera GL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):555-60. PubMed ID: 26412797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis].
    Uelbelhart B; Rizzoli R
    Rev Med Suisse; 2012 Jan; 8(324):109-10, 112-5. PubMed ID: 23185820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
    McClung M; Harris ST; Miller PD; Bauer DC; Davison KS; Dian L; Hanley DA; Kendler DL; Yuen CK; Lewiecki EM
    Am J Med; 2013 Jan; 126(1):13-20. PubMed ID: 23177553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety issues with bisphosphonate therapy for osteoporosis.
    Suresh E; Pazianas M; Abrahamsen B
    Rheumatology (Oxford); 2014 Jan; 53(1):19-31. PubMed ID: 23838024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to use bisphosphonates safely and optimally.
    Jagpal A; Saag KG
    Rheumatology (Oxford); 2018 Nov; 57(11):1875-1876. PubMed ID: 29165674
    [No Abstract]   [Full Text] [Related]  

  • 8. The safety of osteoporosis medication.
    Hough FS; Brown SL; Cassim B; Davey MR; de Lange W; de Villiers TJ; Ellis GC; Lipschitz S; Lukhele M; Pettifor JM;
    S Afr Med J; 2014 Apr; 104(4):279-82. PubMed ID: 25118550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates in the treatment of osteoporosis.
    Diab DL; Watts NB
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):487-506. PubMed ID: 22877426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic holidays in osteoporosis: Long-term strategy of treatment with bisphosphonates].
    Moro Álvarez MJ; Neyro JL; Castañeda S
    Med Clin (Barc); 2016 Jan; 146(1):24-9. PubMed ID: 26048545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and potential risks of bisphosphonate therapy A narrative review.
    El Osta L; El Osta N; El Osta H
    J Med Liban; 2016; 64(4):228-37. PubMed ID: 29845849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication.
    Silverman S; Kupperman E; Bukata S
    Cleve Clin J Med; 2018 Nov; 85(11):885-893. PubMed ID: 30395525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.
    Hanley DA; McClung MR; Davison KS; Dian L; Harris ST; Miller PD; Lewiecki EM; Kendler DL;
    Am J Med; 2017 Jul; 130(7):862.e1-862.e7. PubMed ID: 28359721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?
    McClung M
    Clin Obstet Gynecol; 2013 Dec; 56(4):743-8. PubMed ID: 24177063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteoporosis].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2013 Jan; 9(369):125-31. PubMed ID: 23409650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.
    Brown JP; Morin S; Leslie W; Papaioannou A; Cheung AM; Davison KS; Goltzman D; Hanley DA; Hodsman A; Josse R; Jovaisas A; Juby A; Kaiser S; Karaplis A; Kendler D; Khan A; Ngui D; Olszynski W; Ste-Marie LG; Adachi J
    Can Fam Physician; 2014 Apr; 60(4):324-33. PubMed ID: 24733321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
    Horning JA; Czajka J; Uhl RL
    Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].
    Mawatari T
    Clin Calcium; 2010 Nov; 20(11):1743-7. PubMed ID: 21066910
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
    Di Fede O; Fusco V; Matranga D; Solazzo L; Gabriele M; Gaeta GM; Favia G; Sprini D; Peluso F; Colella G; Vescovi P; Campisi G
    Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.